Total Payments
$3,937
2024 Payments
$18.94
Companies
19
Transactions
215
Medicare Patients
12,914
Medicare Billing
$974,196
Payment Breakdown by Category
Food & Beverage$3,698 (93.9%)
Education$239.28 (6.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,698 | 208 | 93.9% |
| Education | $239.28 | 7 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $732.23 | 40 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $429.57 | 32 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $405.72 | 24 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $384.27 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $284.46 | 7 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $274.91 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $262.08 | 20 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $259.35 | 15 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $219.05 | 12 | $0 (2019) |
| PFIZER INC. | $176.81 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.94 | 1 | Janssen Pharmaceuticals, Inc ($18.94) |
| 2023 | $14.54 | 1 | Philips Electronics North America Corporation ($14.54) |
| 2021 | $132.10 | 1 | BOSTON SCIENTIFIC CORPORATION ($132.10) |
| 2020 | $39.76 | 2 | Amgen Inc. ($20.89) |
| 2019 | $1,053 | 60 | Amgen Inc. ($356.11) |
| 2018 | $1,312 | 76 | Astellas Pharma US Inc ($254.15) |
| 2017 | $1,366 | 74 | SANOFI-AVENTIS U.S. LLC ($180.65) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2023 | Philips Electronics North America Corporation | (4067) Tack Endovascular Systems BTK (Device) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Medical Device | ||||||
| 12/01/2021 | BOSTON SCIENTIFIC CORPORATION | WOLVERINE CORONARY CUTTING BALLOON (Device) | Food and Beverage | In-kind items and services | $132.10 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/28/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Cardiovascular | ||||||
| 01/07/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiology | ||||||
| 12/19/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiology | ||||||
| 12/05/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Cardiology | ||||||
| 11/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology | ||||||
| 10/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiology | ||||||
| 10/10/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Cardiovascular | ||||||
| 09/10/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiology | ||||||
| 09/05/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,487 | 5,172 | $1.3M | $247,685 |
| 2022 | 22 | 3,300 | 5,306 | $1.1M | $244,905 |
| 2021 | 21 | 3,138 | 5,127 | $903,868 | $266,804 |
| 2020 | 20 | 2,989 | 4,581 | $762,715 | $214,802 |
Total Patients
12,914
Total Services
20,186
Medicare Billing
$974,196
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 770 | 1,468 | $408,764 | $142,020 | 34.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 342 | 347 | $303,952 | $20,755 | 6.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 754 | 1,106 | $65,254 | $12,602 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $40,204 | $11,801 | 29.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 165 | $32,670 | $11,286 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 61 | $25,010 | $9,390 | 37.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 114 | 114 | $217,010 | $7,046 | 3.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 63 | $24,003 | $6,481 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 49 | $18,424 | $5,527 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 263 | 439 | $5,268 | $3,680 | 69.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 173 | 177 | $15,045 | $2,934 | 19.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 42 | 42 | $36,876 | $2,435 | 6.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 266 | 329 | $10,857 | $2,300 | 21.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 173 | 177 | $10,089 | $1,928 | 19.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 73 | 184 | $8,278 | $1,363 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $3,679 | $1,289 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,757 | $1,207 | 32.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 34 | 39 | $7,293 | $964.36 | 13.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 77 | 197 | $3,152 | $827.40 | 26.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 11 | 16 | $4,544 | $569.36 | 12.5% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 21 | 31 | $6,603 | $395.88 | 6.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 20 | 20 | $2,080 | $371.61 | 17.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 12 | 12 | $1,764 | $282.69 | 16.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 12 | 13 | $1,547 | $231.03 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 773 | 1,523 | $407,420 | $151,340 | 37.1% |
About Dr. Ronald Cuffe, MD
Dr. Ronald Cuffe, MD is a Nuclear Cardiology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295708253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Cuffe, MD has received a total of $3,937 in payments from pharmaceutical and medical device companies, with $18.94 received in 2024. These payments were reported across 215 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,698).
As a Medicare-enrolled provider, Cuffe has provided services to 12,914 Medicare beneficiaries, totaling 20,186 services with total Medicare billing of $974,196. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Poughkeepsie, NY
- Active Since 02/09/2006
- Last Updated 09/07/2018
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1295708253
Products in Payments
- ELIQUIS (Drug) $534.05
- ENTRESTO (Drug) $429.57
- Corlanor (Drug) $406.00
- XARELTO (Drug) $377.30
- Repatha (Biological) $298.89
- BRILINTA (Drug) $222.82
- PRADAXA (Drug) $219.05
- PRALUENT (Drug) $187.01
- WOLVERINE CORONARY CUTTING BALLOON (Device) $132.10
- AMS 700 (Device) $125.00
- Impella (Device) $122.81
- BYSTOLIC (Drug) $94.04
- PRALUENT ALIROCUMAB INJECTION (Biological) $84.85
- MULTAQ (Drug) $72.34
- Pacemakers (Device) $58.52
- LEXISCAN (Drug) $56.15
- Lexiscan (Drug) $30.31
- CHANTIX (Drug) $30.23
- LOKELMA (Drug) $27.77
- VIAGRA (Drug) $18.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Cardiology Doctors in Poughkeepsie
Dr. Anthony Messina, M.d, M.D
Nuclear Cardiology — Payments: $15,351
Nuclear Cardiology $15,351
Mark Harrison, Md, MD
Nuclear Cardiology — Payments: $3,410
Nuclear Cardiology $3,410
Dr. William Lee, Md Phd Facc, MD PHD FACC
Nuclear Cardiology — Payments: $1,757
Nuclear Cardiology $1,757
Dr. Julie Ling, Md Facc, MD FACC
Nuclear Cardiology — Payments: $1,591
Nuclear Cardiology $1,591